![]() |
¡@¡@¡· »O¥_¥«°Êª««OÅ@³B¡@½²¸Î¤¯
¡½
¡@¡@¥¦¬O¤@ºØ«¬ºA»P¤}ÂΡ]Toxoplasma gondii¡^¬Û¦üªº±H¥ÍÂΡAª½¨ì1988¦~¡A¦b¬ü°ê¥¿¦¡³Qµoªí¨Ã©R¦W¬°·s¥]ÂÎ(Neospora caninum)¡C·s¥]ÂλP¤}ÂάۦP§¡¬°µ´¹ï²ÓM¤º±H¥ÍÂΡC·s¥]ÂÎ¥Dn¥H¤TºØ§ÎºA¦s¦b©ó°Êª«²Õ´¤¤¥]¬A¡GÅnÅé(cyst)¡BÅnÅ餺ªºbradyzoites¤Îµõ´Þ¤l(tachyzoites)¡C·s¥]Âίg(Neosporosis)¬O¥Ñ·s¥]ÂÎ(Neospora caninum)©Ò¤Þ°_ªº¯e¯f¡A¬OÄÝ©óapicomplexanªºìÂΡC¥Ø«e¤wª¾¹D¥¦ªº²×±J¥D¬Oª¯¡F¥BÃÒ¹ê¥i¸g¤f¹¤J§ZÅn¤ÎL½L·P¬V¨Ó¶Ç¼½³\¦h°Êª«¡A¨ä¥¦ªº±J¥D½d³ò«Ü¼s¡A·s¥]Âίg¦b¤ü¡B¤û¡B°¨¡Bºø¦Ï¡B¤s¦Ï¤Î³À¤]·|¤Þ°_¬y¡B¦º²£¡A³y¦¨¸gÀÙ¤Wªº·l¥¢¡A©Ò¥H¦b§@¬°¤¤¶¡±J¥Dªº¤Ï¯ì°Êª«³y¦¨L¨à«§l¦¬¡B¦º²£©Î¬y²£¡C¸ÓÂΦb¥ú¾ÇÅã·LÃè¤U·s¥]ÂΤΤ}ÂΪºµõ´Þ¤l(tachyzoites)«Ü¬Û¦ü¡A¦ý¥i§Q¥Î¶WÅã·Lµ²ºc¨Ó°Ï§O¶EÂ_¡A¥i¥Î¶¡±µ¿Ã¥ú§ÜÅé´ú¸Õªk§@¬°¦å²M¾Ç¶EÂ_(Dubey et al., 1988b)¡A©Î¬O§Q¥Î§K¬Ì²Õ´¤Æ¾ÇªkŲ©w¥X²Õ´¤¤ªº·s¥]ÂÎ(Lindsay and Dubey, 1989c)¡C
¡@¡@²{¤wª¾·s¥]ÂΪº²×±J¥D¬Oª¯(McAllister et al., 1998)¡A¥B¨ä±J¥D½d³ò«Ü¼s¡C¦b¤w³Qµoªí¤åÄm¤¤¡A¦ÛµM·P¬Vªº±J¥D¥]§t¦³¡G¤ü¡B¤û¡Bºø¦Ï¡B¤s¦Ï¡B°¨¤Î³À¡C¹êÅç·P¬V¦¨¥\ªº°Êª«¥]§t¦³¡G¤p¹«¡B¤j¹«¡B¤ü¡Bª°¡B¤s¦Ï¡B¿ß¡Bºø¦Ï¡B¬ü¬w¤p¤g¯T¡B½Þ¡B¨F¹«¡B¨ß¤Î¤ûµ¥¡C¤s¦Ï¸g±`³Q´yz¬°¤ü·sÌU¤lÂÎì¥Í°Êª«ªº¤¤¶¡±J¥D¡A¥Dnªí²{¬°¤ÏÂЬy²£¨Ã¦ñ¦³L½Lª¢©ML¨à¸£ª¢¡CRafael Carneiro Costaµ¥¤H±q¤Ú¦è¦Ì¯Ç´µ¦N©Ô´µ¦{¦ÛµM·P¬Vªº¤s¦Ï¤¤¤ÀÂ÷¥Xªº¨âºØ¤ü·sÌU¤lÂε߮è¡A°Êª«¦b²Ä¤@¶g¥X²{±j¯Pªº²Ä¤@«¬T»²§U²ÓM(Th1)¤ÏÀ³¡A¦å²M©MµÊŦ¤¤«Pª¢©Ê细M¦]¤l¡]¥Dn¬OIFN-£^©MTNF-£\¡^ªí²{¥ç¼W¥[¡C
¡@¡@Jamal Gharekhaniµ¥¤H¦b¥ì®Ô¦a°Ïªº¤s¦Ï¥ÎELISA§Þ³N¤ÀªRªº¤ü·sÌU¤lµß§ÜÅé¡A¨ä¦å²M¶§©Ê²v¬°6.2%(2/28)¡A¨ä¤¤2·³¥H¤W¤½¤s¦Ï¡]11.1%¡^¹ïN. caninumªºIgG³Ì°ª¡]54.4%¡^¡A¦Ó·P¬V²v©M¦~ÄÖ¦³ÅãµÛ®t²§¡A¥t¦³¬y²£¥vªº¦Ï°¦¡]18/30, 60%¡^©M°w¹ïN. caninum ªºIgG§e¥¿¬ÛÃö¡A¥i¯à¬O³y¦¨¤s¦Ï¬y²£©M¸gÀÙ·l¥¢ªºì¦]¡CArlan Araújo Rodriguesµ¥¤H©ó¤Ú¦è°¨©Ô¥§©ù¦{½Õ¬d¤s¦Ï¤¤¤ü·sÌU¤lÂΪºÁ`Åé¦å²M¶§©Ê²v¬°26.4%¡]101/382¡^¡A¨äÅãµÛ¬ÛÃö¦MÀI¦]¯À¬O¦~ÄÖ¡B¦Ï°é¦aªOÃþ«¬¡B¹}¾i¤è¦¡¡BÁý¾i¡Bªª³õºØ´Ó±¿n¡B¿ß±µÄ²¹}®Æ¡BÅXÂΡB°Êª«±O®_³õ¡B¬y²£¥v©Mª¯©M¿ßªº¦s¦b¡CC Eleniµ¥¤H¬y²£¤s¦ÏL¨àªº¤j¸£¤¤ÀË´ú¨ìì¥Í°Êª«Ån¸~¡A³q¹LPCRŲ©w¬°¤ü·sÌU¤lÂΡC¦¿¤ó³ø§i«ü¥X»OÆW¤¤«n³¡¦a°Ï (¶³ªL¡B¹Å¸q¤Î»O«n)¨Å¦Ï¤Î±O®_¦×¦Ïªº¬y¦æ¯f¾Ç½Õ¬d¬°0 %¡A¥t¦bŦ¾¹¡B¹}®Æ¤Î¶¼¤ô¼Ë¥»¤¤¬ÒµL·s¥]ÂήֻĤ§ÀË¥X¡C²»Ê¼Ýµ¥¤H¨Ï¥Î¤@¯ëPCR¡Bnested PCR©ó¦Ï¨Å¤¤ÀË´ú·s¥]ÂÎDNA¡A¶§©Ê²v¤À§O¬°(3/582)¡B22.3% (130/582)¡A¨ä¤¤122Ó¬°ªì¨Å¼Ë¥»¡A¬ù¥e93%(113/122)¡C
¡@¡@¸g¤f·P¬V¬OÂǥѹ¤J¤üÁT«K¤º±Æ¥Xªº§ZÅn¦Ó·P¬V¡F¥ç¥i¸g¥ÑL½L¶Ç¼½·P¬V¡A¨ä°Êª«¥]¬A¡G¤ü¡]Dubey and Lindsay, 1989b; Cole et al., 1995b¡^¡B¿ß¡]Dubey et al., 1992c¡^¡A¤Î¤p¹«¡]Cole et al., 1995a; Long and Baszler, 1996¡^¤Î¤û(Dubey et al., 1992; Barr et al., 1994b; Schares et al., 1998)¡A¦Ó²Õ´ÅnÅé¡]tissue cysts¡^¡BÅnÅ餺ªºbradyzoites¤Îµõ´Þ¤l¡]tachyzoites¡^§¡¥i©è§ÜÆQ»Ä-G³J¥Õ²G¡]HCl-pepsin solution¡^ªº®ø¤Æ¦Ó¸g¤f·P¬V¡A¬GÃÒ¹ê¦×¹©Ê°Êª«¥iÂÇ¥ÑÄá¹·P¬Vªº²Õ´¦Ó³Q·P¬V¡]Dubey, 1990¡^¡CÅnÅ餺ªºbradyzoites¥i©è§ÜÆQ»Ä-G³J¥Õ²G¡]HCl-pepsin solution¡^¡A¥B¨ä¦b4¢J¤¤¥i¦s¬¡14¤Ñ¡A¦Ó¦b-20¢J¤¤1¤Ñ§Y¥¢¥h·P¬V¤O¡C©Ò¥H¦×¹©Ê°Êª«¥i¯à¬°¥Í¬¡¥v¤¤ªº¤@³¡¥÷¡]Lindsay and Dubey, 1990b¡^¡CµM¹êÅç«Ç·P¬V·s¥]ÂΪº¤èªk¡A¥]¬A¡G¥Ö¤Uª`®g¡B¸¡µÄª`®g¡B¦Ù¦×ª`®g¡BÀR¯ßª`®g¤Î¤fªAµ¥¤è¦¡¡A¨Ó·P¬V§K¬Ì§í¨îªº¹êÅç°Êª«¡C
¡@¡@¦Ó§Q¥Î²ÓM°ö¾iªº·s¥]Âεõ´Þ¤l¨Óµû¦ô¨ä§Ü¥Í¯À±Ó·P©Ê¡A¨ä¤¤§í¨î¾¯Â÷¤l«¬§Ü¥Í¯À(lasalocid, maduramicin, monensin, narasin,¤Îsalinomycin),macrolides (azithromycin, clarithromycin,¤Îerthromycin),¥|Àô¯À(doxycycline¤Îminocycline)¤Îlincosamide§Ü¥Í¯À§¡¦³®Ä ( Lindsay et al., 1994, 1996d)¡C¦b²ÓM°ö¾i¤¤Arprinocid, nitrofurazone, robenidine, decoquinate¤Îdiclazusil¹ïµõ´Þ¤l¤]¦³®Ä¡A¦ýamprolium. metronidazole, paromomycin¤Îroxarsone«h®ÄªG®t©Î§¹¥þµL®Ä(Lindsay et al., 1994)¡C¥t©ó¤p¥Õ¹«±µºØ·s¥]ÂΫá¨C¤Ñ§ëÃÄ4-20mg Amprolium¨ÃµLªk¹w¨¾·s¥]Âίg¤Î¤p¹«¦º¤`¡C¦b¹êÅç·P¬V«á3-14¤Ñ¡A¨C¤Ñ¶¼¤ô§ëÃÄ4mg Sulfadiazine¡A«h¦³90%«OÅ@¤O¡C¦Ó¹êÅç·P¬Vµõ´Þ¤l«á³Ìªì7¤Ñ¡A¶¼¤ô§ëÃÄAmprolium©ÎSulfadiazine 4mg§¡¥i¦³®ÄªvÀø·s¥]Âίg¡C
¡@¡@ÂǥѤWzÄm¦^ÅU´Á«Ý¯à¹ï©ó¦Ï·s¥]ÂΨ¾ªv¤W¦³©Ò¯q§U¡A¥B¥ç¯à¹ï¦Ï¹}¾iªÌÀò¨ú¥þ¤è¦ì·sª¾ªº°T®§¡A°ß¦³¤£Â_ºë¯q¨Dºë¡A¤~¯à³Ð³y°Êª«°·±dºÖ¬ç¤Î´£¤É¾i¦Ï¤á¦¬¤J¡AÅý¤j²³¨É¦³Àu½è¦Ï°¦²£¥Í²£«~¡C
¡@
![]() |
¡¶¤£¾A¦X¦Ï°¦ªº¹}¾iÀô¹Ò |
¡@
¡½
¦¿¦uùÚ¡C»OÆW¤¤«n³¡¦a°Ï¤s¦Ï¤}ÂλP·s¥]ÂηP¬V¤§¬y¦æ¯f¾Ç¬ã¨s¡C2014¡C
²»Ê¼Ý¡C¥H¤À¤l¥Íª«¾Ç¶EÂ_·s¥]Âίg©ó¨Å¥Ä¼Ë¥»¡C2012¡C
Arlan Araújo Rodrigues, Sara Silva Reis, Elinalva da Silva Moraes, José Gracione do Nascimento Souza Filho, Maria Helena Dos Santos Reis, Thais Agostinho Martins, Juliana Correa Bernardes, Beatriz De Souza Lima Nino, João Luis Garcia, Thiago Vinícius Costa Nascimento, Ivo Alexandre Leme da Cunha. Seroprevalence and risk factors for Neospora caninum and Toxoplasma gondii in goats of Maranhão State, Brazil. Vet Parasitol Reg Stud Reports. 2021 Dec;26:100634.
Barr, B. C., Conrad, P. A., Sverlow, K. W., BonDurant, R. H., Ardans, A. A., Lliver, M. N. and Conrad, P. A. 1994b. Experimental reproduction of Bovine fetal Neospora infection and death with a bovine Neospora isolate. J. Vet. Diagn. Invest., 6: 207-215.
C Eleni , S Crotti, E Manuali, S Costarelli, G Filippini, L Moscati, S Magnino. Detection of Neospora caninum in an aborted goat foetus. Vet Parasitol. 2004 Sep 2;123(3-4):271-4.
Cole, R. A., Lindsay, D. S., Blagburn, B. L., Sorjonen, D. C. and Dubey, J. P. 1995b. Vertical transmission of Neopspora caninum in dogs. J. Parasitol., 81: 208-211.
Dubey, J, P., Hattel, A. L., Lindsay, D. S. and Topper, M. J. 1988b. Neonatal Neospora caninum infected in dogs: Isolation of the causative agent and experimental transmission. J. Am. Vet. Med. Assoc., 193: 1259-1263.
Dubey, J. P. and Lindsay D. S. 1989b. Transplacental Neospora caninum infection in dogs. Am. J. Vet. Res., 50: 1578-1579.
Dubey, J. P., Hamir, A. N., Shen, S. K., Thulliez, P. and Rupprecht, C. E. 1993. Experimental Toxoplasma gondii infection in raccoons(Procyon lotor). J. parasitol., 79: 548-552.
Dubey, J. P., Koestner, A. and Piper, R. C. 1990d. Repeated transplacental transmission of Neospora caninum in dogs. J. Am. Vet. Med. Assoc., 197: 857-860.
Dubey, J. P., Lindsay, D. S., Anderson, M. L., Davis, S. W. and Shen, S. K. 1992c. Induced transplacental transmission of Neospora caninum in cattle. J. Am. Vet. Med. Assoc., 201: 709-713.
Jamal Gharekhani, Bijan Esmaeilnejad, Hadi Rezaei, Mohammad Yakhchali, Heidar Heidari, Mahsa Azhari. Prevalence of anti-Neospora caninum antibodies in Iranian goats. Ann Parasitol. 2016;62(2):111-4.
Lindsay, D. S. and Dubey, J. P. 1989c. Immunohistochemical diagnosis of Neospora caninum in tissue sections. Am. J. Vet. Res., 50: 1981-1983.
Lindsay, D. S., Butler, J. M., Blagburn, B. L. 1996d. Efficacy of decoquinate against Neospora caninum tachyzoites in cell cultures. Vet. Parasitol., in press.
Lindsay, D. S., Rippey, N. S., Cole, R. A., Parsons, L. C., Dubey, J. P., Tidwell, R. R. and Blagburn, B. L. 1994. Examination of the activities of 43 chemotherapeutic agents against Neospora caninum tachyzoites in cultured cells. Am. J. Vet. Med. Res., 55: 976-981.
Long, M. T. and Baszler, T. V. 1996. Fetal loss in Balb/c mice infected with Neospora caninum. J. Parasitol., in press.
McAllister, M. M., Dubey, J. P., Lindsay, D. S., Jolley, W. R., Wills, R. A., McGuire, A.M. 1998. Dogs are definitive hosts of Neospora caninum. Int. J. Parasitol., 28:1473-1478.
Rafael Carneiro Costa , Leonardo Pereira Mesquita, Ivam Moreira de Oliveira Jr, Dennis Albert Zannato, Lucas Emanuel Dos Santos Mesquita, Daniel Arrais Biihrer, Cristina de Oliveira Massoco Salles Gomes, Mary Suzan Varaschin, Paulo César Maiorka .The pathogenicity of two Neospora caninum goat strains in a BALB/c mouse model. Exp Parasitol. 2019 Oct;205:107736.